Clin2
NCT07387341Likely a fitNot yet recruiting

Mosquito repellent trial for children

Malaria TransmissionMalaria PreventionMalaria

Part of Infections clinical trials.

This trial tests a mosquito repellent that is placed in homes to see if it helps prevent malaria. It is for children living in the area.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
22,815 people
Ages
1 year to 15 years
Study type
Interventional

Who can take part

  • Child must be between 1 and 15 years old
  • Must have lived in the area for at least 4 months and been home the night before the survey
  • A parent or guardian must give permission
  • If the child is 12 or older, they must also agree to take part

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06232954Recruiting
Testing a mosquito-repelling device to prevent malaria in kids

This trial is testing a special device that releases a scent to repel mosquitoes, aiming to reduce malaria in young children in Uganda. If you have a child under 5 and are willing to use the device in your home, this study could help protect your child from malaria.

Jinja
NCT07246525Not yet recruiting· Phase 4
Malaria prevention pills for school children

This trial tests giving school-age children a short course of medicine to prevent malaria and see if it can reduce the spread of the disease in the community. It involves taking pills at set times during the school year.

Kampala
NCT06529237Recruiting
Malaria study for children and pregnant women in Mozambique

This study looks at how malaria spreads in Mozambique by testing children and pregnant women with fever. If you or your child may have malaria, participating could help researchers understand and fight the disease better.

Manhiça, Maputo Province
NCT06881732Not yet recruiting· Phase 1
Testing a new malaria vaccine by mosquito bite

This trial uses a genetically modified malaria parasite given by mosquito bite to safely test a new vaccine approach in healthy volunteers. If you qualify, you'll help researchers understand how the body defends against malaria.

Melbourne, Victoria
NCT07712263Not yet recruiting
Testing a new spray in a malaria-prevention program

This study looks at whether adding a special device (the Guardian Spatial Emanator) to the AZVINIR II azithromycin program helps prevent malaria. It involves checking households and health centers in high-malaria areas in Africa.

Niamey
NCT05690841Recruiting· Phase 3
Medication campaign to eliminate malaria in nearby villages

This Phase 3 trial tests whether giving malaria medicine to people in high-risk households (a “mass drug administration” campaign) can stop local relapses and eliminate vivax malaria. If you live close to a recent malaria case, you may be offered a preventive dose, based on age and medical safety checks.

Iquitos

Hear when a new Malaria Transmission trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.